Super Micro's woes, and the outlook for a company with no auditor ... Shouldn't companies like Novo Nordisk and Eli Lilly just be able to sail into the sunset by supplying these drugs? The answer is ...

Operator: Ladies and gentlemen, welcome to Cassava Sciences Report for the Third Quarter 2024. At this time, all participants are in a listen-only mode.

Cassava Sciences, Inc. ( NASDAQ: SAVA) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Rick Barry - President & Chief Executive Officer Eric Schoen - Chief Financial Officer ...

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

Later, Eli Lilly ... the company and the EU, after the British firm said it would be unable to meet its promised levels of initial vaccine supply. This led to the bloc demanding answers and ...

Conditions are getting a bit more challenging for the drugmaker.

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...

Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...

Eli Lilly And Co. (NYSE:LLY) is a major pharmaceutical company that develops and manufactures medicines. It specializes in treatments for various diseases, including diabetes, cancer, and mental ...

Unfortunately, for shareholders of the company, it failed to meet expectations in its most recent earnings report on Oct. 30. And the numbers weren't even close. Eli Lilly didn't have a bad ...